The largest and longest study of the obesity drug Wegovy has shown people maintain significant weight loss for at least four ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four ...
Altimmune is developing Pemvidutide, a drug that shows promising results in fat and weight loss. See why Pemvidutide's ...
Weight-suppressant drugs have helped millions to lose weight. But once they're stopped, people tend to regain most of what ...
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by ...
Pharmaceutical giants highlight other benefits of weight-loss drugs from reducing heart attacks to tackling liver disease as ...
The number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and ...
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a ...
Frantic demand for drugs to treat obesity from Novo Nordisk, Eli Lilly, and others could support a global market worth an eye-watering $60 billion within the next decade, according to a ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found. The largest ...